UT-Southwestern Medical Center: Study Reveals Unexpected Mechanism of Drug Resistance in Kidney Cancer
June 12, 2024
June 12, 2024
DALLAS, Texas, June 12 (TNSres) -- The University of Texas Southwestern Medical Center issued the following news release:
For nearly two decades, how kidney cancer becomes resistant to rapalog drugs has baffled the scientific community. Now a study by researchers at UT Southwestern Medical Center's Kidney Cancer Program sheds light. Published in the Proceedings of the National Academy of Sciences, the study "Unconventional Mechanism of Action and Resistance to Rapalogs in Renal . . .
For nearly two decades, how kidney cancer becomes resistant to rapalog drugs has baffled the scientific community. Now a study by researchers at UT Southwestern Medical Center's Kidney Cancer Program sheds light. Published in the Proceedings of the National Academy of Sciences, the study "Unconventional Mechanism of Action and Resistance to Rapalogs in Renal . . .